Qubit Pharmaceuticals Accelerates Drug Discovery With Hybrid Quantum Computing
The promise of quantum computing is to solve unsolvable problems. And companies are already making headway with hybrid approaches — those that combine classical and quantum computing — to tackle… Read Article
NVIDIA Partners With NHS Trusts to Deploy AI Platform in UK Hospitals
A consortium of 10 National Health Service Trusts — the publicly funded healthcare system in England — is now deploying the MONAI-based AIDE platform across four of its hospitals, providing… Read Article
From Code to Clinic, Smart Hospital Tech Boosts Efficiency, Sustainability in Medicine
NVIDIA is collaborating with clinical organizations across Europe to bring AI to the point of care, bolstering clinical pathways with efficiency gains and new data dimensions that can be included… Read Article
The Man With 100,000 Brains: AI’s Big Donation to Science
Jorge Cardoso wears many hats, and that’s appropriate given he has so many brains. A hundred thousand of them to be exact. Cardoso is a teacher, a CTO, an entrepreneur,… Read Article
First Wave of Startups Harnesses UK’s Most Powerful Supercomputer to Power Digital Biology Breakthroughs
Four NVIDIA Inception members have been selected as the first cohort of startups to access Cambridge-1, the U.K.’s most powerful supercomputer. The system will help British companies Alchemab Therapeutics, InstaDeep,… Read Article
UK Biobank Advances Genomics Research with NVIDIA Clara Parabricks
UK Biobank is broadening scientists’ access to high-quality genomic data and analysis by making its massive dataset available in the cloud alongside NVIDIA GPU-accelerated analysis tools. Used by more than… Read Article
NVIDIA CEO Unveils ‘First Big Bet’ on Digital Biology Revolution with UK-Based Cambridge-1
Introducing NVIDIA’s “first big bet” on the digital biology revolution, NVIDIA CEO Jensen Huang Wednesday unveiled Cambridge-1, a $100 million investment that promises to harness partnerships across the U.K. for… Read Article
Perfect Harmony: Pharma’s MELLODDY Consortium Joins Forces with NVIDIA to Supercharge AI Drug Discovery
Pharmaceutical companies have traditionally kept their data close to the vest because collaboration’s side effects may include compromising intellectual property and losing the edge over competitors. But sharing data has… Read Article